Delivery Order SPE2DE24D0013-SPE2D625F0ALF
- Not listed
- The U.S. Defense Department's Medical Supply Chain organization awarded a $2,024 firm fixed-price delivery order to Cepheid Inc. on August 7, 2025, with an ultimate completion date of August 14, 2025. The delivery order, designated XPRSTREPA-10, was issued without a set-aside designation to the Sunnyvale, California-based molecular diagnostics manufacturer. This delivery order represents a continuation of Cepheid's longstanding federal contract relationship, drawing from the company's existing...
- This delivery order, issued on July 28, 2025, awards Cepheid Inc. a firm fixed-price contract valued at $1,190.28 for molecular diagnostic solutions under a Defense Logistics Agency Medical Supply Chain program. The contract is set to be completed by August 11, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. The award reflects the company's established role as a key supplier of diagnostic systems and reagents to federal defense and healthcare agencies,...
- The U.S. Defense department's Medical Supply Chain agency awarded a delivery order valued at $1,440 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on July 28, 2025. This firm fixed-price delivery order, designated as 4568910320 and issued under the GXCDIFF/EPI-10 vehicle, carries an ultimate completion date of August 4, 2025, with no set-aside designation. The award represents a continuation of the federal government's procurement of Cepheid's advanced...
- The Defense Department's Medical Supply Chain awarded a $3,424.65 firm fixed-price delivery order to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, on August 7, 2025. The delivery order, designated XPRSMVP-10 with contract number 4569031066, is scheduled for ultimate completion by August 14, 2025, with performance taking place at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents a continuation of the...
- The U.S. Defense Department's Medical Supply Chain organization awarded Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, a $4,108.25 firm fixed-price delivery order (Contract No. 4569031063) on August 7, 2025, with completion scheduled for August 14, 2025. This delivery order carries no set-aside designation and represents a procurement of diagnostic solutions from Cepheid's established product portfolio. The award leverages Cepheid's expertise in molecular...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $20.4K to Cepheid Inc. on July 25, 2025, for molecular diagnostic solutions. Designated as Contract Number 4568895371 with the identifier XPCOV2/FLU/RSV-10, this firm fixed-price delivery order is set to be completed by August 1, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract involves diagnostics testing solutions, specifically targeting...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,815 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 7, 2025, with ultimate completion targeted for August 21, 2025. This firm fixed-price delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is likely associated with one of Cepheid's existing Indefinite Delivery Vehicle contracts with...
- The Defense Logistics Agency's Medical Supply Chain division awarded an $6.8K firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer specializing in infectious disease testing solutions. This delivery order, issued on August 5, 2025, with an ultimate completion date of August 12, 2025, is designated as XPCOV2/FLU/RSV-10 and relates to diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV). The...
- The Defense Logistics Agency awarded a delivery order to Cepheid Inc. valued at $26,312.70 under a firm fixed-price contract with an ultimate completion date of August 12, 2025. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing. This delivery order carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. This award represents a...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $2,723.58 by the Defense Department's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 12, 2025. The contract, which carries no set-aside designation, represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicles with the Department of Veterans Affairs. Cepheid specializes in advanced...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F0ALFDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $9,779.30 to Cepheid Inc. on August 1, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, issued under contract number XPRSMVP-10, carries no set-aside designation and represents a discrete procurement of molecular diagnostic solutions for defense-related medical supply needs. The work will be performed at Cepheid's facility in Sunnyvale, California. Cepheid, a leading manufacturer of molecular diagnostic systems and test kits, fulfills this delivery order as part of its broader engagement with federal healthcare agencies. The company specializes in GeneXpert diagnostic systems and associated reagents used to detect infectious diseases including COVID-19, influenza, RSV, MRSA, and other clinical conditions. Cepheid maintains significant existing federal vehicle contracts, including two Indefinite Delivery contracts with the Department of Veterans Affairs valued at approximately $32.8 million and $2.5 million respectively, which provide comprehensive molecular diagnostic testing capabilities. This delivery order aligns with the Department of Defense's medical supply chain support requirements and reflects Cepheid's established position as a trusted provider of diagnostic technologies to federal defense and healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 8/1/25 |